Q2050 Doxorubicin - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Doxorubicin

Brand Name:

Doxil

Strength:

10 mg

HCPCS:

Q2050

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antitumor Antibiotic

Minor Drug Class:

Anthracycline

Oral (Y/N):

No

FDA Approval Year:

1995

FDA Discontinuation Year:

CMS Effective Date:

July 1, 2013

CMS Discontinuation Date:

Status:

In Use